Mark Einziger Email

Director Project Management . Ascendia Pharmaceuticals

Current Roles

Employees:
67
Revenue:
$13.5M
About
Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations
Ascendia Pharmaceuticals Address
661 US Highway One
North Brunswick, NJ
United States
Ascendia Pharmaceuticals Email
Ascendia Pharmaceuticals Phone Numbers
732 640-0058

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.